.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Chinese Patent Office
Daiichi Sankyo
Farmers Insurance
Merck
Johnson and Johnson
Medtronic
Dow
US Army

Generated: July 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076059

« Back to Dashboard
NDA 076059 describes LISINOPRIL, which is a drug marketed by Apotex Inc, Wockhardt, Sandoz, Invagen Pharms, Lupin, Aurobindo, Prinston Inc, Sun Pharm Inds Ltd, Ivax Sub Teva Pharms, Accord Hlthcare, Watson Labs, Hikma Intl Pharms, Mylan, and Teva, and is included in thirty-one NDAs. It is available from seventy-five suppliers. Additional details are available on the LISINOPRIL profile page.

The generic ingredient in LISINOPRIL is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

Summary for NDA: 076059

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 076059

Suppliers and Packaging for NDA: 076059

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LISINOPRIL
lisinopril
TABLET;ORAL 076059 ANDA Actavis Pharma, Inc. 0591-0405 0591-0405-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-0405-01)
LISINOPRIL
lisinopril
TABLET;ORAL 076059 ANDA Actavis Pharma, Inc. 0591-0405 0591-0405-05 500 TABLET in 1 BOTTLE, PLASTIC (0591-0405-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Jul 1, 2002TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jul 1, 2002TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jul 1, 2002TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Medtronic
Moodys
Deloitte
Accenture
Queensland Health
AstraZeneca
Fuji
Teva
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot